@ARTICLE{
author={Otasevic Vladimir,Antic Darko A,Maiti Kausik,Cho Heidi,Lunney Nancy,Dabic Darko,Learn Chris},
year={2025},
title={Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis},
journal={BLOOD},
volume={146},
number={},
pages={6315-6316},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Otasevic Vladimir,Cho Heidi,Antic Darko A,Maiti Kausik,Lunney Nancy,Dabic Darko,Learn Chris},
year={2025},
title={Cyclophosphamide versus methotrexate for treating large granular lymphocyte leukemia: Real-world data insights},
journal={BLOOD},
volume={146},
number={},
pages={4490-4490},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cho Heidi,Lunney Nancy,Maiti Kausik,Otasevic Vladimir,Learn Chris},
year={2024},
title={An Endothelial Activation and Stress Index (EASIX) Based Predictive Model for Neurotoxicity and CytokineRelease Syndrome (CRS) after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-CellTherapy for Relapsed/Refractory Multiple Myeloma (RRMM)},
journal={BLOOD},
volume={144},
number={},
pages={610-610},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cho Heidi,Maiti Kausik,Lunney Nancy,Otasevic Vladimir,Learn Chris},
year={2024},
title={Comparative Analysis of Mortality from Serious Adverse Events Associated with CAR-T Therapies},
journal={BLOOD},
volume={144},
number={},
pages={5102-5102},
document_type={Meeting Abstract},
}